Journey Clinical launched a ketamine prescribing service for independent psychotherapy practices. Journey Clinical provides independent licensed mental health professionals and private psychotherapy practices with prescription services to provide safe, effective, and transformative ketamine-assisted psychotherapy (KAP) for their consumers. KAP is used as treatment for patients with treatment-resistant depression. Currently, KAP services are only available from chain clinics, or from a small number of self-employed psychotherapists. Journey Clinical is now accepting applications from psychotherapists seeking to grow their practice with KAP.
Under Journey Clinical’s model, member psychotherapists gain access to trained in-house ketamine prescribers to provide KAP as part of their practice. The membership provides a complete clinical and evidence-based system to maximize the safety and efficacy of KAP and enhance consumer outcomes.
Journey Clinical was founded in 2020. It completed its pre-seed funding round in March 2021, with key support from Neo Kuma Ventures, PsyMed Ventures, and Beckley Waves, and opened a seed round in June 2021.
To support its prescription service and ensure the highest quality care for consumers, Journey Clinical partnered with Fluence to provide expert-driven KAP training to its members. Journey Clinical members also have access to the leading outcomes-focused electronic health records system for psychedelic therapy through a partnership with Osmind.
This was reported by Journey Clinical on June 15, 2021.